IGFBP7 and persistent truncus arteriosus: In summary, our data demonstrate that targeted IGFBP7 inhibition through therapeutic delivery of neutralizing IGFBP7 antibody rescued TAC-induced HF in mice, which supports it as a potential therapeutic intervention to limit stress-mediated senescence and pro-fibrotic cardiac injury.